An Interactive Skill Webinar for PhD Students, Postdoctoral Researchers, and Academic Scientists Seeking to Transition into ...
The 2025 AseBio Report shows a Spanish biotech ecosystem that is not only expanding, but attracting capital at a new scale: ...
Jeremie Capron, of research firm Robo Global, calls these companies the "enablers." They provide the tools and services to help a drug developer identify, test and ultimately manufacture a product.
Hosted on MSN
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
Investors Should Know: The GLP-1 and broader metabolic disease drug space is advancing rapidly, with next-generation oral formulations, triple-acting compounds, and combination therapies moving ...
Palatin Technologies Stock is quiet on the news front this Sunday, so the focus shifts to a background look at the biotech’s development path, pipeline orientation and where the shares stand in the ...
Biotechnology recruiting is hot. It''s more active than IT and telecommunications and it isn''t suffering the shortages in other areas of healthcare, says Frank Heasley, PhD, President and CEO, of ...
Amgen stock closes the week with a solid large-cap biotech profile. With no fresh company-specific headlines, the Sunday focus turns to the group’s history, management and role in the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results